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Summary
Objective: Activation of granulocytes causes a considerable rise in the concentration of lactoferrin (Lf) in synovial ﬂuid (SF). We here inves-
tigate consequences thereof on signal transduction and the balance between catabolic and anabolic metabolism in chondrocytes.
Methods: Signal transduction was analysed in cultured chondrocytes by immunodetection of mitogen activated protein kinases (MAPK) and
analysis of Smad2 translocation to the nucleus. Expression levels of matrix metalloproteinases (MMPs) and of aggrecan were measured by
reverse-transcription-PCR. The proteolytic activity of MMPs was ascertained by zymography. Expression of the low-density-lipoprotein-recep-
tor-related-protein-1 (LRP-1), a Lf receptor for signalling, was assayed by immunohistochemistry in cartilage and in cultured chondrocytes by
immunoblotting.
Results: We found LRP-1 expressed in dedifferentiated chondrocytes in culture and in cartilage tissue preferentially on the articular surface
where it can encounter Lf within SF. Lf stimulated proliferation of chondrocytes, comparable to transforming growth factor-b1 (TGFb1) and
activated p38 and the extracellular-signal regulated-kinases 1/2 (ERK1/2) within minutes. Surprisingly, Lf induced nuclear Smad2 transloca-
tion, a signal pathway ascribed to TGFb receptor activation. Lf signiﬁcantly increased the levels of catabolic indicators such as MMP1, MMP2,
MMP3 and MMP13 and inhibited aggrecan synthesis.
Conclusion: Lf is a robust regulator of chondrocyte metabolism, comparable to TGFb1. The catabolic inﬂuence together with the proliferative
stimulus indicates a function as an early phase cytokine, enhancing MMPs, necessary for degradation of damaged tissue and stimulating pro-
liferation of chondrocytes, necessary for reconstruction.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Inﬂammatory signals ﬁne-tune their action leading to repair,
while imbalance attributes to cartilage destruction. Chon-
drocytes are the sole source for cartilage synthesis and
a concerted signalling initiates proliferation of the normally
resting chondrocytes in deeper zones of cartilage and
induces matrix synthesis.
In acute arthritis, neutrophils, attracted to synovial ﬂuid
(SF), release stimulants that alter the metabolism of syno-
viocytes and chondrocytes1. In the granules of neutrophils
lactoferrin (Lf) is abundant1,2. While serum levels range
from 2 to 7 mg/ml, local concentrations in SF rise several
fold during arthritis2e4. Lf functions not only by iron scav-
enging but binds to receptors at many target cells and
impinges on cellular signalling pathways. Among them is
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117(MAPK)5e7. After prolonged activation p38 mediates the
induction of the catabolic program in cartilage and impairs
the ability of chondrocytes to produce type II collagen and
aggrecan8,9. If Lf is able to activate these pathways in
chondrocytes, it would uncover a functional role at the
site of inﬂammation4. Cornish et al. found a proliferative
effect of human and bovine Lf on osteoblastic cells and
also ovine chondrocytes10. Furthermore, Lf was described
to induce mitotic activity when binding to low-density-lipo-
protein-receptor-related-protein-1 (LRP-1) in osteoblastic
cells and thereby to promote cell proliferation likely via
activation of extracellular-signal regulated-kinases (ERK)11.
We previously identiﬁed (LRP-1) as a membrane receptor
on liver cells12 that binds Lf with a Kd at about 10 mg/ml. Be-
sides cargo transport, the functions of LRP-1 have been ex-
tended to signalling capacities in a wide range of cellular
events13,14. We therefore analysed whether expression of
LRP-1 in cartilage is present in areaswhere Lf concentrations
under pathologic conditions exceed Kd values. We then de-
termined signalling that is initiated in human chondrocytes
andwhich changes in cellmetabolismandproliferationoccur.
We used physiologic to pathologic concentrations of Lf to ﬁnd
a dose dependency in the crucial range.
Transforming growth factor-b 1 (TGFb1) is among the
best studied molecules regulating cartilage metabolism in
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parallel to Lf to validate signal transduction in relation to
a standard cytokine.
Typically, activation of collagenases is mediated by sig-
nal transduction. Matrix metalloproteinase 1 (MMP1 or col-
lagenase 1) can be considered the most important
degrading protease in the superﬁcial layers of cartilage in
inﬂammation, while MMP13 (collagenase 3) is implicated
in the remodelling phase18. MMP2 (gelatinase A) can acti-
vate proenzymatic forms of MMP1319,20 and we therefore
analysed whether changes of activity levels are executed
by Lf. From these investigations we anticipate to depict
cell signals induced by Lf and the contribution to the regula-
tion of cartilage degradation or remodelling.Material and methodsISOLATION AND CELL CULTURE OF HUMAN ARTICULAR
CHONDROCYTES (HACs)HACs and cartilage tissue slices were collected with informed consent
and approval of the local ethical committee as described16. For determina-
tions of MAP kinase activation, cells, treated with bovine Lf (Morinaga) or
phosphate buffered saline (PBS) (control treatment), were solubilised with ly-
sis buffer as described16. Lysates were frozen in liquid nitrogen, thawed and
centrifuged (13.000 g, 15 min, 4C). LRP-1 levels were determined in cells,
treated as described above, of passages two, 10 and >20 (P2, P10, P> 20).
For fractionation experiments, HACs seeded in 75 cm2 ﬂasks (Greiner), were
grown to conﬂuence. After 2 h of incubation with human recombinant TGFb1
(10 ng/ml in 4 mM HCl, 0.1% BSA (Calbiochem)), bovine Lf (50 mg/ml in
PBS) or vehicle alone (control cells), fractionation of HACs was performed
using the FractionPREP Cell Fractionation system (Biovision, Mountain
View, CA) according to the manufacturer’s protocol.SDS GEL ELECTROPHORESIS AND WESTERN BLOTTINGSubcellular fractions, separated on 10% SDS-polyacrylamide gels were
transferred to nitrocellulose as previously described16. LRP-1 was detected
by a peptide antibody that recognizes its 85 kDa b-chain21. The phosphory-
lation status of ERK1/2 (p44/42 MAPK) and p38 was determined using anti-
bodies against the activated forms (phospho-p44/42 MAPK and phospho-
p38 MAPK antibody, Cell Signalling). Smad2 was detected by monoclonal
anti-Smad2 antibody (BD Biosciences). Equal protein amounts were con-
trolled by b-actin staining (Anti- b-Actin, Sigma). Signals were visualised
by chemiluminescence (SuperSignal, Pierce). Digital captures analysed
using ChemiImager 4400 (Biozym) with software to compute the integrated
optical density (IOD) of the bands. Protein concentration was determined
using the BCA Protein Assay Kit (Pierce).PROLIFERATION ASSAYCell proliferation was assessed by the colorimetric 3-(4,5-dimethyl thiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Gerbu). Cells were al-
lowed to attach in 96-well tissue culture plates overnight (Greiner Bio-One)
(10.000 cells per well), followed by incubation with Lf or human recombinant
TGFb1 (in 1 PBS or 4 mM HClþ 1% BSA respectively) for 7 days. Cells
treated with vehicle alone served as controls. After treatment, 20 ml of MTT
(0.5 mg/ml in PBS), dissolved in 200 ml Dulbecco’s Modiﬁed Eagle Medium
(DMEM), were added for three hours. The optical density of the dimethylsulf-
oxide-extracted dye was determined at 595 nm (plate reader, Bio-Rad).IMMUNOHISTOCHEMISTRYParafﬁn sections from femoral cartilage were deparafﬁnised with xylene,
washed with ethanol of descending concentrations (100%e70%) and
placed in water. After blocking (10% FCS), sections were incubated with pri-
mary antibody overnight. After washing, incubation with 3% H2O2, and
washing, secondary HRP-conjugated antibody was added (45 min). Sec-
tions were stained with DAB (Diaminobenzidine tetrachloride) reagent.
Nuclei were stained with Hemalaun (Merck) and excess stain eluted with
HCleEthanol. Sections were placed into Scott solution (20 mM KHCO3,
80 mM MgSO4) and in ethanol in ascending concentrations (70%e100%)
and washed with xylene. Finally they were mounted with Eukitt, covered
with coverslips and documented in a Zeiss Axiovert 135 microscope using
METAVIEW.IMMUNOCYTOCHEMISTRYHACs grown on glass coverslips were incubated with Lf (50 mg/ml, 2 h)
and ﬁxed with paraformaldehyde (4%). After permeabilization with Triton
X-100 (0.2%) and blocking with glycin (1%), Smad2 was detected by mono-
clonal anti-Smad2 antibody (BD Biosciences) and visualised by FITC
labelled second antibody in a Zeiss Axiovert 135 (METAVIEW). Nuclei
were stained (Hoechst 33258).GENE EXPRESSION ANALYSIScDNA from RNA was prepared as described16. Gene-speciﬁc primer
sequences were designed using the PRIMER 3 software available in web-
based formats. Speciﬁcity of primers was checked with NCBI Blast Software
(Supplement Table 1). Cycle numbers and annealing temperatures were
chosen dependent on the gene of interest (Supplement Table 2). Samples
were run on ethidium-bromide-gels for visualisation. IODs were calculated
using the One-Dscan software (Scanalytics).ZYMOGRAPHYThe assay was performed using the culture supernatants collected after
a 7-day incubation period from cells grown in 96 well plates for the MTT test
analysis. The amount of supernatant loaded onto the gel was normalised to
cell numbers assessed byMTT test analysis. MMP2 (72 kDa gelatinase) activ-
ity was assayed by zymography in SDS-polyacrylamide gels containing 0.5%
gelatine (Sigma). For MMP3 (caseinolytic) activity assays, 0.1% casein
(Merck) was added to the gel. In SDS gels, the activities of MMPs are pre-
served and also the pro-form exhibits proteolytic activity. Both forms are distin-
guishable by the different electrophoreticmobilities. After electrophoresis, gels
were washed in 2.5% Triton X-100 to remove all SDS. After incubation in
50 mmol/l Tris (pH 7.5) and 10 mmol/l CaCl2 at 37
C overnight, gels were
stained with 0.1% Coomassie brilliant blue R250 and digital images captured.ResultsLACTOFERRIN AND TGFb1 INDUCE PROLIFERATION OF HACsMitotic activity22,23 in human chondrocytes was deter-
mined comparing the growth rates in medium supple-
mented with 10, 50 or 100 mg Lf per ml with standard
growth-medium (Control). The ﬁrst concentration is as nor-
mally found in SF and the latter typically in inﬂammatory
conditions24. To evaluate effects, we compared them with
TGFb1 stimulated chondrocytes16,25e28.
From the cell densities pictured in [Fig. 1(a)], profound
growth stimulation is evident (A: Control, B: Lactoferrin
100 mg/ml). To determine whether Lf acts speciﬁcally, we
performed incubations with transferrin, a closely related
member of the iron transporting glycoprotein family. Using
the iron saturated (holo-) and depleted (apo-) form allowed
to differentiate whether iron supply triggered growth. The
lack of efﬁcacy of transferrin to induce growth [Fig. 1(A, C,
D)] indicates that not nutrient supply by iron delivery but
a speciﬁc sequence/structure signalling is operational.
This moreover so, as there is considerable sequence
homology between transferrin and Lf that apparently can
be discriminated by a receptor ligand interaction only.
We enumerated this stimulation by MTT-test [Fig. 1(b)].
Within 7 days, growth was raised to 180% with 10 mg/ml Lf
(P< 0,05) and to 250% with 50 and 100 mg/ml Lf
(P< 0,001) in the culture medium. This promotion was com-
parable to theoneproducedbyTGFb1 (10 ng/ml (P< 0,001).LACTOFERRIN RECEPTOR (LRP-1) EXPRESSIONTo support an involvement of LRP-1 in the Lf induced prolif-
eration,weanalysedLRP-1 in chondrocyte cell cultureat differ-
ent stages of differentiation and in distinct zones of cartilage.
We appliedWestern blotting for LRP-1 in cell extracts from
increasingly dedifferentiated chondrocytes within passage 2
(P2), passage 10 (P10) and passage> 20 (P> 20). In
Fig. 1. Stimulation of cell growth by Lf, transferrin and TGFb1. a) Representative phase-contrast photomicrographs (100) of HACs grown in
DMEM containing 10% FCS only (A) or with Lf (B), apo-transferrin (C) and holo-transferrin (D) (each 100 mg/ml) for 7 days, are shown. Scale
bar¼ 25 mm (AeD). b) Effect of Lf and TGFb1 on the proliferative activity of HACs assessed by MTT test. Data are presented as the relative
changes of activity of cells treated with Lf or human recombinant TGFb1 at the indicated concentrations to that of control cells (DMEM and
10% FCS only). Means (SD, error bars) were calculated from ﬁve independent experiments (performed in quadruplicates). Signiﬁcant
changes to controls: *: P< 0,05; ***: P< 0,001 (One-sample t-test).
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from round shaped cells (P2) towards elongated ﬁbroblast
like dedifferentiated cells (P10 and P> 20) are visible. West-
ern blot band densities of LRP-1 show low intensity in P2 and
rising intensities in P10 and P> 20. Thus, LRP-1 expression
seems regulated by differentiation signals in cultured HACs.
We then explored cartilage tissue from superﬁcial, middle
and deep zone for LRP-1 in vivo expression. There was no
background staining with second antibody only and DAB
colour development [Fig. 2(b), (AeC)]. A typical zonal distri-
bution with distinct differentiation stages became overt. In
the superﬁcial zone (A) at the articular surface, dedifferenti-
ated, stressed cells with elongated morphology that often
do not express any of the matrix components are common.In the middle zone (B) we frequently observed couplets of
chondrocytes of the type of activated chondrocytes and col-
umn shape stacks that are ascribed to synthesise collagen
type IIA and aggrecan. In the deep zone adjacent to calci-
ﬁed tissue (C), chondrocytes are in a hypertrophic state
and express preferentially collagen type X, along with cells
with signs of pycnotic nuclei and condensed cytoplasm
reminiscent of cell necrosis.
These zones showed a distinct expression pattern of
LRP-1 (right column): in the superﬁcial cartilage area (D)
and the deep zone (F), we found unambiguous staining
for LRP-1. Both regions of cartilage contact SF or serum
with access to Lf. In the middle zone, differentiated chon-
drocytes were low in or negative for LRP-1 staining (E).
Fig. 2. a) LRP-1 protein levels of HACs from passage 2 (P2), 10 (P10) and >20 (P> 20) were analysed by immunoblotting using an antibody
that recognizes the 85 kDa transmembrane b-chain of LRP-1. Cell protein standardized sample loading was controlled by BCATM Protein As-
say Kit and the efﬁciency of transfer by Ponceau-S staining. The morphology of HACs of the respective passages is shown below by phase-
contrast micrographs (magniﬁcation: 100). Scale bar¼ 25 mm. b) Parafﬁn sections of human femoral cartilage tissue and detection of LRP-1.
First antibody: LRP-1 peptide antibody (rabbit), recognizing the b-chain of LRP-1, second antibody: HRP-conjugated anti-rabbit IgG, visualised
by standard DAB procedure. Nuclei were stained with Hemalaun. AeC: Control stain with Hemalaun and second anti-rabbit IgG only. DeF:
LRP-1 ﬁrst antibody plus second; HACs in sections from the superﬁcial zone (A, D). middle zone (B, E) and deep zone adjacent to bone (C, F);
(magniﬁcation: 400). Scale bar¼ 570 mm (A-F).
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Fig. 4. Modulation of MMP and aggrecan expression levels by Lf
Fig. 3. HAC were incubated with bovine Lf (50 mg/ml) in DMEM con-
taining 10% FCS. ERK1/2 (p44/42) and p38 activation induced by
short (30 min) and long (72 h) term incubations were determined
by western blot analysis using phosphospeciﬁc antibodies. Equal
sample loading was controlled by b-actin or panERK staining.
IODs were calculated using the ChemiImager 4400. a) Representa-
tive set of bands from one replicate experiment. b) Summarized
data are presented as relative change to control activity (IOD-
treated/IOD-control). Each bar represents the mean of three inde-
pendent experiments (performed in duplicates, error bars: SD).
Signiﬁcant changes to control: * ¼P < 0.05, ** ¼P < 0.01
(one-sample t-test).
121Osteoarthritis and Cartilage Vol. 18, No. 1LACTOFERRIN ACTIVATES MAPKs AND p38and by TGFb1. a) HACs were treated with human recombinant
TGFb1 (10 ng/ml) (left) or bovine Lf (50 mg/ml) (right) for 24 h in
DMEM (þ10% FCS). Expression levels of MMP1, 2, 3, 13, aggre-
can and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were assessed by RT-PCR. A representative picture of two inde-
pendent experiments (performed in triplicates) is presented. b) Re-
sults with Lf are summarized and presented as relative changes to
control (normalised to GAPDH). Each bar represents the mean of
three independent experiments (performed in duplicates, error
bars: SD). Signiﬁcant changes to control : * : P < 0.05;
***: P< 0.001 (one-sample t-test).We explored whether Lf performs as an ERK stimulator in
HACs andmight providemigratory incentives. In addition, we
measured the p38 activation response to Lf. In Fig. 3 the ac-
tivation levels of p38 and ERK1/2, determined by immuno-
blotting with phosphospeciﬁc antibodies, are shown. After
30 min there was unambiguous activation of both pERK1/2
and p-p38 upon incubation of chondrocytes with Lf. Statisti-
cal analysis of replicate experiments revealed that ERK1
(p44) activation was about 5-fold (P< 0,05), ERK2 (p42)
was raised approximately 2.5 fold (P< 0,05) and p38 activa-
tion levels were about 30 fold (P< 0,01) higher. As signal du-
ration is critical for the responses in cells, we extended the
incubation times to 72 h to check the long time effects. After
this treatment the activity of ERK2 phosphorylation was at
control levels, ERK1 activation even below control levels
(P< 0,01). On the other hand, p38 was found to remain
slightly elevated (about 2efold).LACTOFERRIN CHANGES EXPRESSION LEVELS OF MMPs AND
AGGRECANWe were interested whether and to what extend Lf af-
fected MMP expression, that could result from MAP-Kinase
activation. In Fig. 4 the expression levels of MMP1, 2, 3,
and 13, assessed by reverse-transcription-PCR (RT-PCR)
are presented. TGFb1, a documented powerful regulatorycytokine in chondrocytes was used for comparison
[Fig. 4(a left panel)] with the effects of Lf (right panel).
Both clearly induced the expression of MMP1 and 13, while
MMP3 levels were only responsive to Lf. The mean ratios of
ODs under Lf treatment vs vehicle treatment are shown in
[Fig. 4(b)] together with statistical signiﬁcance of the repli-
cate experiments. Incubation with Lf for 24 h increased
the expression levels of MMP1 about 2.7 fold (P< 0,05)
and MMP3 levels 2.5 fold (P< 0.001). MMP13 mRNA ex-
pression did not result in measurable band densities in un-
stimulated cells and statistical analysis was not performed.
Nevertheless, after stimulation with Lf, MMP13 levels were
readily detectable [Fig. 4(a, right panel)]. Activation of
MMP3 expression with Lf but not with TGFb1 accentuates
the role of Lf to shift HAC cultures towards a catabolic state.
Fig. 5. a) Gelatinase activity in the supernatant of HAC stimulated
with Lf or TGFb1 for 7 days. Representative ﬁgures of the effects
of Lf and TGFb1 on the activity of MMP2, assessed by gelatine-zy-
mography analysis, are shown. MMP9 (92 kDa gelatinase) secre-
tion by HACs could not be approved as the amount found in the
supernatant of cells was equal to the levels found to be present
in the media prior to incubating cells (not shown). b) Caseinolytic
activity in the supernatant of HAC stimulated with Lf or TGFb1 for
7 days. Representative ﬁgures of the effect of Lf and TGFb1 on
the extracellular activity of MMP3, assessed by casein-zymography
analysis, are shown.
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tion of p38 that might be sufﬁcient to shut down aggrecan
synthesis. Indeed, we found signiﬁcant reduction of
mRNA expression of aggrecan with Lf but not TGFb1. Ag-
grecan is an indicator for cartilage material resynthesis,
what further supports the importance of Lf in shifting chon-
drocytes towards a catabolic state.LACTOFERRIN MODULATES ENZYMATIC ACTIVITY OF MMPsWe determined the activity of MMPs on the protein level
by zymography analysis to verify the changes in mRNA at
the levels of protein activity. In Fig. 5 we show MMP2,
determined by gelatine zymography and MMP3 by casein
zymography, in the supernatant of HAC after 7 days of incu-
bation with recombinant TGFb1 or Lf.
In agreement with the mRNA determinations, the pro-
MMP2 protein quantities were unaltered by TGFb1 as well
as Lf. Active MMP2, however, was elevated in samples in-
cubated with Lf, while TGFb1 reduced its activity to near un-
detectable activities [Fig. 5(a)].
Incubation with Lf resulted in a dose dependent stimula-
tion of MMP3 activation [Fig. 5(b)]. No effect in MMP3
caseinolytic activity was observable when cells were incu-
bated with TGFb1.LACTOFERRIN ACTIVATES Smad2 TRANSLOCATION INTO
NUCLEIWe observed considerable homology between Lf and
TGFb1 induced regulation of metabolism. We therefore ex-
amined the activity of the TGFb/Smad pathway, rapid trans-
fer of Smad2 from cytosol into the nucleus, to control
TGFb1 activity and as a control also in the presence of Lf.
In [Fig. 6(a)] we show immunoﬂuorescence micrographs
with cells stained for Smad2. Cells grown in standard
medium show a distinct spotted distribution of Smad2 in
the cytosol while nuclear areas are dark and unstained.
Upon incubation with TGFb1 there was the expected shift
of Smad2 from cytosol to intranuclear localisation (not
shown). Surprisingly with Lf, the distribution also changed
rapidly and nuclei become intensely stained while thecytoplasmic staining abates. To enumerate the effect we
performed cell fractionation and determined the ratios of
Smad2 in the nuclei of untreated cells and such treated
with TGFb1 or LF. In [Fig. 6(b)] the relative ratios of
Smad2 levels are given. With TGFb1 the ratio of levels of
treated vs control was >4 and with Lf added the ratio was
found to be >7.Thus these results indicate that Lf is able
to utilise the Smad signalling pathway that transduces the
TGFb signals.Discussion
Characteristic differences in gene expression patterns
between normal and arthritic cartilage raise the question
which mediators govern the changes. Interleukin-1 (IL-1),
tumour necrosis factor-a (TNF-a) and TGFb1 are consid-
ered dominant, nevertheless their effects are enhanced or
silenced considerably by co-players not known in detail. In
inﬂammation, granulocytes are recruited to the joints, re-
lease inﬂammatory molecules and also raise considerably
the concentration of Lf in SF. The effects of elevated Lf
levels on chondrocytes we describe here suggest a role
as signal modulator in chondrocytes that is equally
effective as and interacts with TGFb signalling.
Originally known as a secretory component, protecting
against bacterial growth by its iron scavenging property,
novel data emphasize the function of Lf in cell signalling af-
ter binding to cell surface receptors. Activation of MAPK
was shown to induce anabolism in osteoblasts leading to
augmentation of bone mass11 and in addition also to prolif-
eration of ovine chondrocytes10. We here showed that hu-
man chondrocytes react likewise with proliferation and the
extent thereof is as pronounced as with TGFb. The Lf levels
that produced signiﬁcant responses, were between 10 and
50 mg/ml, approximately 10 fold above normal levels and
with 100 mg/ml proliferation was saturated. This dose re-
sponse thus produces no effect at physiologic levels and
maximal effects at levels that are found in SF in severe in-
ﬂammation. We here used bovine Lf as it is used frequently
by the majority of researchers. The issue emerges whether
human Lf or apo Lf have the same potential. Knowing struc-
tural differences causing differences in efﬁcacy would
advance our understanding substantially.
The expansion of cell number induced by Lf could lead to
augmentation of cartilage mass as reported for Lf treated
osteoblasts. However, when we measured synthesis of ag-
grecan, representing an indicator of anabolic metabolism, it
was markedly inhibited. Moreover, catabolic proteins such
as MMPs were signiﬁcantly up regulated by Lf, reminiscent
to results obtained in early and late osteoarthritic cartilage
by DNA array technology29. Thus, in human chondrocytes,
Lf does not mimic the effects in osteoblasts regarding anab-
olism. Although Lf acts similar to TGFb1, initiating Smad
translocation and MAP kinase activation, the signals are
interpreted differently and the expression pattern is regu-
lated in the chondrocyte’s own way.
We found up regulation for MMP1 and 13 similar to
TGFb1, while MMP3 was induced by Lf only. MMPs-1, -3,
and -13 can degrade aggrecan and it is thus reasonable
that Lf inhibited aggrecan expression30. We previously re-
ported that TGFb1 does not elevate p-p38 in chondro-
cytes16 contrasting the extensive activation by Lf. This is
a likely explanation for the down regulation of aggrecan
mRNA expression31 that is enhanced normally by TGFb1.
In addition, Lf further aggravated catabolism by posttransla-
tionally inducing the conversion of inactive MMP2 pro-form
Fig. 6. a) Nuclear stain (A, B) and cellular distribution of Smad2 (C,D) in untreated control cells (A,C) and after 2 h of incubation with Lf
(50 mg/ml) (B,D) are shown by immunocytochemistry. b) Cell fractionation and immunoblotting evaluated by densitometry of Smad2 band
intensities of nuclear fractions. The ratios of IODs of Lf and TGFb1 treated vs untreated control cells are presented. Each bar represents
the mean of three independent experiments (performed in duplicates, error bars: SD). Signiﬁcant changes are indicated: *¼P< 0.05,
***¼P< 0.001 (one-sample t-test).
123Osteoarthritis and Cartilage Vol. 18, No. 1
124 N. Brandl et al.: Lactoferrin signalling in chondrocytesto active MMP2, while TGFb1 abolished this conversion. It
needs to be determined whether MMP1 mRNA activation
by Lf results in higher protein levels.
Interestingly, Lf has occasionally antiproliferative effects
for example on endothelial or cancer cells by down-regulat-
ing G1 cyclin-dependent kinases32. This must be triggered
by so far unknown mechanisms. As a ﬁrst evidence for
such, we found nuclear translocation of Smad2 induced
by Lf, an entirely new ﬁnding suggesting crosstalk between
Lf and TGFb signalling. LRP-1 is able to mediate Smad ac-
tivation by its ability to function as a type II receptor33 that
forms a signalling competent dimer with TGFb type I recep-
tor. Thus Lf e LRP1 might dimerise with type I receptor un-
covering Smad kinase activity on the intracellular portion.
Interestingly, LRP1, by sequestering HFz1, disrupts the re-
ceptor/coreceptor complex formation, leading to the repres-
sion of the canonical Wnt signalling34. The occurrence of
LRP-1 on chondrocytes positioned at the surface of the car-
tilage where Lf is readily accessible strongly suggests a no-
table function. It needs to be determined which of the many
signalling capabilities of LRP1 underlie the signalling events
we observed and which are different from the transcriptional
crosstalk between Smad, ERK1/2, and p38 MAP kinase
pathways that governs the TGFb-induced aggrecan expres-
sion31. Certainly, the effects of Lf need to be evaluated in
the presence of inhibitors and we used SB202190 for p-
38 and U0126 as MEK inhibitor which abolishes any ERK
phosphorylation in our system and produces so far approx-
imately 50% reduction (data not shown).
Binding of LF to ﬁbroblasts was reported to regulate the
ERK pathways through LRP1, what changed cell migration
pattern35,36,37. As we found ERK effects in chondrocytes it
would be interesting to explorewhethermigration of chondro-
cytes could be facilitated by Lf not only by inducing degrada-
tion of extracellular matrix but also by activating cell motility.
Thus, although the interpretation of the signalling effects
induced by Lf is still speculative, the metabolic effects we
found let assume that Lf-release into SF facilitates remodel-
ling of cartilage by enhancing the degradation of cartilage
material. This, however, may blunt resynthesis of cartilage
upon prolonged presence. Therefore Lf levels in SF were
never practical to predict the outcome of arthritic destruc-
tion38. High levels of Lf might be beneﬁcial and correlate
with a recuperation within a certain time window only, but
outside this time window, high levels will correlate with in-
creasingly severe pathology. If such a mechanism is oper-
ative, blocking of function or release of Lf could be
beneﬁcial for cartilage regeneration.Conﬂict of interest
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Supplementary material for this article may be found, in
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